Puri Pharmaceuticals (300630.SZ) announced that the company recently received a voriconazole injection issued by the Norwegian Medicines Agency...
According to the Zhitong Finance App, Prilicom Pharmaceuticals (300630.SZ) announced that the company recently received a marketing license for voriconazole injections issued by the Norwegian Drug Administration. Voriconazole is a broad-spectrum triazole antifungal drug that treats aggressive aspergillosis, candidemia in patients with non-neutropenia, severe invasive infections caused by fluconazole-resistant Candida, and severe infections caused by Actinomycetes and Fusarium spp. It is mainly used to treat patients with progressive potentially life-threatening fungal infections and prevent invasive fungal infections in high-risk patients receiving allogeneic hematopoietic stem cell transplantation (HSCT).